Royal Bank of Canada
SLXP

Royal Bank of Canada’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Royal Bank of Canada’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,000
Closed -$3.46M – 6943
2015
Q1 		$3.46M Buy
+20,000
New +$2.94M ﹤0.01% 1848

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's SLXP Position: Q2 2015 in Review

Royal Bank of Canada sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 4,825 shares — an estimated $834K sold.

Royal Bank of Canada first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $16.8M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Royal Bank of Canada reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 4,825 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $834K.
  • Royal Bank of Canada first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Royal Bank of Canada's SALIX PHARMACEUTICALS LTD DEL position peaked at $16.8M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Royal Bank of Canada's 13F filing for Q2 2015, filed 14 Aug 2015.